Key facts
- Cristcot’s last known valuation is $13.2M (Jun 2015).
- It has raised $62.7M across 6 recorded rounds; the latest was Early Stage VC ($10.5M) in Apr 2025.
- Notable investors include Gideon Ventures, Scientia Ventures, Shepherd Kaplan Krochuk, StartUp Health.
- Cristcot has filed 7 Form Ds with the SEC since 2013, most recently Jun 2025 ($10.5M sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Cristcot
Funding rounds
6 roundsAbout Cristcot
Developer of a disposable suppository applicator designed to assist in rectal suppositories. The company's applicator offers hygienic administration of suppository medication for treating constipation, gastrointestinal diseases, functional bowel disorders, nausea, migraine headaches, chronic pain and malaria, enabling care workers to hygienically and comfortably administer rectal suppositories to patients.
- Sector
- Healthcare
- HQ
- Concord, MA, United States
- Founded
- 2008
- Employees
- 14
- Website
- cristcot.com/
- Ownership
- Privately Held (backing)
Cristcot doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cristcot shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cristcot in its N-PORT filings yet. We sweep new filings monthly.